To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC5012 | Tacrine-pyrimidone Hybrid 27g |
Novel Potent Dual AChE/GSK-3 Inhibitor for the Treatment of Alzheimers Disease
More description
|
|
| DCC5011 | Tachyplegina-4 |
Novel Irriversible Inhibitor of Parasite Motility and Invasion
More description
|
|
| DCC5010 | Tachyplegina-2 |
Novel Inhibitor of Parasite Motility and Invasion
More description
|
|
| DCC5009 | Tachyplegina |
Novel Inhibitor of Parasite Motility and Invasion
More description
|
|
| DCC5008 | Tachioside |
Natural radical scavenger on ABTS
More description
|
|
| DCC5007 | T6603185 |
Novel inhibitor of the catalytic functions of peroxiredoxin (Prx) and thioredoxin (Trx) systems
More description
|
|
| DCC5006 | T5975164 |
Inhibitor of HIV-1 Assembly that Targets the Phosphatidylinositol (4,5)-bisphosphate Binding Site of the HIV-1 Matrix Protein
More description
|
|
| DCC5005 | t5660138 |
Novel Inhibitor of Adenovirus Gene Transfer
More description
|
|
| DCC5004 | t5660136 |
Novel Inhibitor of Adenovirus Gene Transfer
More description
|
|
| DCC5003 | T3ss Inhibitor Iii-7 |
Novel inhibitor of the type III secretion system (T3SS), acting as a anti-microbial agent against Xanthomonas oryzae pv. oryzae (Xoo)
More description
|
|
| DCC5002 | T-2 Toxin Triol |
Type-A trichothecene mycotoxin
More description
|
|
| DCC5001 | T16a(inh)-d01 |
Selective class D inhibitor of the Ca -activated Cl- Channel, Ano1(TMEM16A)
More description
|
|
| DCC5000 | T16a(inh)-b01 |
Selective class B inhibitor of the Ca -activated Cl- Channel, Ano1(TMEM16A)
More description
|
|
| DCC4999 | T-10106 |
Novel potent PPARγ antagonist with much improved drug-like properties and promising pharmacokinetic profile
More description
|
|
| DCC4998 | T-0632 |
Potent and selective CCKA receptor antagonist
More description
|
|
| DCC4997 | T0511-4424 |
Novel COX-2 inhibitor
More description
|
|
| DCC4996 | Szv558 |
Potent inhibitor of both rodent and human MAO-B, proved to be safe in high doses with no hERG and mutagenic activities and demonstrated neuroprotection in an in vivo chronic model of PD
More description
|
|
| DCC4994 | Synthalin Dihydrochloride |
K+ channel blocker
More description
|
|
| DCC4993 | Synstab A |
Novel microtubule-stablizer
More description
|
|
| DCC4992 | syn22269076 |
Novel Mycobacterium tuberculosis growth inhibitor
More description
|
|
| DCC4991 | Syn-1 Scr Peptide |
Negative control of Syn-1 peptide, having the same amino acid composition as Syn-1 peptide, but a scrambled sequence
More description
|
|
| DCC4990 | Syn-1 Peptide |
Novel potent and specific inhibitor of syncytin-mediated cell fusion, completely blocking cell fusion at 1.6 μg/ml
More description
|
|
| DCC4989 | Syk-in-ii |
Novel inhibitor of the Syk kinase (spleen tyrosine kinase)
More description
|
|
| DCC4988 | Syk-524 |
Novel universal opioid receptor agonist
More description
|
|
| DCC4987 | Sy-5609 |
Novel highly potent and selective CDK7 inhibitor, demonstrating broad anti-tumor activity in vivo
More description
|
|
| DCC4986 | S-y048 |
Novel selective OXE receptor antagonist
More description
|
|
| DCC4985 | swertisin |
Potent differentiating agent
More description
|
|
| DCC4984 | Swainsonine |
Natural potent alpha-mannosidase inhibitor, exhibiting antimetastatic, antiproliferative, and immunomodulatory activities
More description
|
|
| DCC4983 | Sw208108 |
Novel clickable tumor-specific irreversible inhibitor of stearoyl CoA desaturase (SCD)
More description
|
|
| DCC4982 | Sv-iii-130s |
D2 dopamine receptor partial agonist in adenylyl cyclase inhibition assay and antagonist in the GIRK and phospho ERK1/2 assays
More description
|
|